Torfs C P, Katz E A, Bateson T F, Lam P K, Curry C J
California Birth Defects Monitoring Program, Emeryville, California 94608-1811, USA.
Teratology. 1996 Aug;54(2):84-92. doi: 10.1002/(SICI)1096-9926(199606)54:2<84::AID-TERA4>3.0.CO;2-4.
In a case-control study of gastroschisis, we evaluated the risks associated with mother's first-trimester use of medications and with hobby or occupational exposures for 110 cases and 220 controls without a birth defect. Mothers of cases and controls were age-matched. For hobby or occupational exposures, we found significantly elevated risks for high levels of solvents (odds ratio (OR) = 3.8; 95% confidence interval (CI) = 1.6-9.2) and for colorants (OR = 2.3; 95% CI = 1.3-4.0). For medications, we found significantly elevated risks for two strong cyclooxygenase inhibitors, aspirin (OR = 4.7; 95% CI = 1.2-18.1) and ibuprofen (OR = 4.0; 95% CI = 1.0-16.0), but not for acetaminophen, a weak cyclooxygenase inhibitor. Periconceptional exposure to X rays was also associated with gastroschisis (OR = 2.5; 95% CI = 1.2-5.5), but exposure to antibiotics, antinauseants, sulfonamides, or oral contraceptives was not. We also found elevated risks for two decongestants, pseudoephedrine (OR = 2.1; 95% CI = 0.8-5.5) and phenylpropanolamine (OR = 10.0; 95% CI = 1.2-85.6). For the group of all decongestants, including also oxymetazoline and ephedrine, the risk was significantly elevated (OR = 2.4; 95% CI = 1.0-5.4). Controlling in multivariate analyses for several demographic and pregnancy variables associated with gastroschisis in a previous analysis [Torfs et al. (1994) Teratology 50: 44-53] did not substantially change the level or direction of the associations. Most of these associations are for vasoactive substances, which supports a vascular hypothesis for the pathogenesis of gastroschisis.
在一项腹裂的病例对照研究中,我们评估了110例腹裂病例和220例无出生缺陷的对照者其母亲在孕早期使用药物以及有爱好或职业暴露相关的风险。病例组和对照组的母亲年龄匹配。对于爱好或职业暴露,我们发现高剂量溶剂(比值比(OR)=3.8;95%置信区间(CI)=1.6 - 9.2)和着色剂(OR = 2.3;95% CI = 1.3 - 4.0)的风险显著升高。对于药物,我们发现两种强效环氧化酶抑制剂阿司匹林(OR = 4.7;95% CI = 1.2 - 18.1)和布洛芬(OR = 4.0;95% CI = 1.0 - 16.0)的风险显著升高,但对弱效环氧化酶抑制剂对乙酰氨基酚则不然。受孕前暴露于X射线也与腹裂有关(OR = 2.5;95% CI = 1.2 - 5.5),但暴露于抗生素、止吐药、磺胺类药物或口服避孕药则无关。我们还发现两种减充血剂伪麻黄碱(OR = 2.1;95% CI = 0.8 - 5.5)和苯丙醇胺(OR = 10.0;95% CI = 1.2 - 85.6)的风险升高。对于包括羟甲唑啉和麻黄碱在内的所有减充血剂组,风险显著升高(OR = 2.4;95% CI = 1.0 - 5.4)。在前一项分析[Torfs等人(1994年)《致畸学》50:44 - 53]中,对与腹裂相关的几个人口统计学和妊娠变量进行多变量分析时进行控制,并没有实质性改变关联的程度或方向。这些关联大多是针对血管活性物质,这支持了腹裂发病机制的血管假说。